MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome-Reference-Cited by-同舟云学术

MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome

Published:2010-09-17 Issue:1 Volume:10 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Byrne Jennifer A,Maleki Sanaz,Hardy Jayne R,Gloss Brian S,Murali Rajmohan,Scurry James P,Fanayan Susan,Emmanuel Catherine,Hacker Neville F,Sutherland Robert L,deFazio Anna,O'Brien Philippa M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-10-497.pdf

Reference47 articles.

1. Bast RC, Hennessy B, Mills GB: The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 2009, 9: 415-28. 10.1038/nrc2644.

2. Shih I-M, Kurman RJ: Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004, 164: 1511-8.

3. Byrne JA, Balleine RL, Schoenberg Fejzo M, Mercieca J, Chiew Y-E, Livnat Y, St. Heaps L, Peters G, Byth K, Karlan BY, Slamon DJ, Harnett P, deFazio A: Tumor Protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer. Int J Cancer. 2005, 117: 1049-54. 10.1002/ijc.21250.

4. Myllykangas S, Himberg J, Bohling T, Nagy B, Hollmen J, Knuutila S: DNA copy number amplification profiling of human neoplasms. Oncogene. 2006, 25: 7324-32. 10.1038/sj.onc.1209717.

5. Baudis M: Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data. BMC Cancer. 2007, 7: 226-10.1186/1471-2407-7-226.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATF1 regulates MAL2 expression through inhibition of miR-630 to mediate the EMT process that promotes cervical cancer cell development and metastasis;Journal of Gynecologic Oncology;2025

2. High MAL2 expression predicts shorter survival in women with triple-negative breast cancer;Clinical and Translational Oncology;2024-05-20

3. Activation of MAL2 by RAD21 inhibits the expression of MHC-I in immune evasion of endometrial cancer;Cytotechnology;2024-04-24

4. Research advances of MAL family members in tumorigenesis and tumor progression (Review);Molecular Medicine Reports;2024-02-14

5. Long noncoding RNA FTX promotes epithelial-mesenchymal transition of epithelial ovarian cancer through modulating miR-7515/TPD52 and activating Met/Akt/mTOR;HISTOL HISTOPATHOL;2023